tirzepatide serotonin and Antidepressants: Key Interactions tirzepatide serotonin syndrome Serotonin Syndrome:

Large population studies of semaglutide and liraglutide users show lower rates of several obesity-associated cancers compared to untreated peers, consistent with the broader benefits of sustained weight loss

Molecular Metabolism , 63 , 101533

A sixth study, VERTIS-CV, evaluating ertugliflozin, is expected to be completed in December 2019 (89)

For semaglutide, this means the drug may remain detectable in your system for approximately 56 weeks after the final injection, though therapeutic effects diminish sooner

One of the things that's potentially a risk for GLP-1 users is if they have pre-existing psychiatric vulnerabilities